Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-089919
Filing Date
2021-07-07
Accepted
2021-07-07 21:01:01
Documents
1
Period of Report
2021-07-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2121160-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2121160-2_4seq1.xml 4 4225
  Complete submission text file 0001104659-21-089919.txt   5577
Mailing Address C/O BIOVEX GROUP, INC. 34 COMMERCE WAY WOBURN MA 10801
Business Address
Coffin Robert (Reporting) CIK: 0001376492 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38596 | Film No.: 211078773

Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Issuer) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)